MARÍA LUISA
NAVARRO GÓMEZ
Profesora asociada de Ciencias de la Salud
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (4)
2012
-
Five-year antibody persistence and safety following a booster dose of combined haemophilus influenzae type b-neisseria meningitidis serogroup c-tetanus toxoid conjugate vaccine
Pediatric Infectious Disease Journal, Vol. 31, Núm. 10, pp. 1074-1077
-
Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: Application of individualized therapy in HIV-infected infants and toddlers
British Journal of Clinical Pharmacology, Vol. 73, Núm. 4, pp. 641-650
2007
-
Immunogenicity and reactogenicity of primary immunization with a novel combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine coadministered with a diphtheria-tetanus- acellular pertussis-hepatitis B-inactivated poliovirus vaccine at 2, 4 and 6 months
Pediatric Infectious Disease Journal, Vol. 26, Núm. 1, pp. 1-7
2006
-
Salvage therapy with abacavir and other reverse transcriptase inhibitors for human immunodeficiency-associated encephalopathy
Pediatric Infectious Disease Journal, Vol. 25, Núm. 12, pp. 1142-1152